Journal article
Development and persistence of patient-reported visual problems associated with serotonin reuptake inhibiting antidepressants
Abstract
BACKGROUND: The majority of antidepressants inhibit serotonin reuptake and include the selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and the serotonin reuptake inhibiting tricyclic antidepressants.
OBJECTIVE: The objective of this study was to investigate and describe the range and impact of reported adverse visual effects linked to serotonin reuptake inhibiting antidepressants.
Authors
Healy D; Mangin D; Lochhead J
Journal
International Journal of Risk & Safety in Medicine, Vol. 33, No. 1, pp. 37–47
Publisher
SAGE Publications
Publication Date
2022
DOI
10.3233/jrs-210018
ISSN
0924-6479